Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Scholar Rock has raised $100.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.
Scholar Rock's investors include ARCH Venture Partners, Samsara BioCapital, Redmile Group, Frazier Healthcare Partners, Blue Owl.
Scholar Rock is headquartered in Cambridge, United States.
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Scholar Rock is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scholar Rock — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/scholar-rock. Accessed October 1, 2026.
VCBacked. (2026). Scholar Rock — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/scholar-rock
{{cite web |title=Scholar Rock — Funding & Investors |url=https://www.vcbacked.co/company/scholar-rock |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated